CV Sciences

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch CV Sciences and buy or sell other stocks, ETFs, and their options commission-free!

About CVSI

CV Sciences, Inc. engages in the development, manufacture, and sale of herbal supplements, CBD products and plant-based food products. Its brands include PlusCBD, PlusHLTH, Cultured Foods, and Lunar Fox. 

CEO
Joseph D. Dowling
CEOJoseph D. Dowling
Employees
44
Employees44
Headquarters
San Diego, California
HeadquartersSan Diego, California
Founded
2010
Founded2010
Employees
44
Employees44

CVSI Key Statistics

Market cap
3.84M
Market cap3.84M
Price-Earnings ratio
-1.63
Price-Earnings ratio-1.63
Dividend yield
Dividend yield
Average volume
441.99K
Average volume441.99K
High today
High today
Low today
Low today
Open price
$0.0186
Open price$0.0186
Volume
0.00
Volume0.00
52 Week high
$0.10
52 Week high$0.10
52 Week low
$0.0145
52 Week low$0.0145

Stock Snapshot

The current CV Sciences(CVSI) stock price is $0.02, with a market capitalization of 3.84M. The stock trades at a price-to-earnings (P/E) ratio of -1.63.

CV Sciences(CVSI) stock opened on 2026-09-16 at $0.02. The price climbed to — and dipped to —.

CV Sciences(CVSI) shares are trading with a volume of 0, against a daily average of 441.99K.

In the last year, CV Sciences(CVSI) shares hit a 52-week high of $0.10 and a 52-week low of $0.01.

In the last year, CV Sciences(CVSI) shares hit a 52-week high of $0.10 and a 52-week low of $0.01.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.